JP2019523767A5 - - Google Patents

Info

Publication number

JP2019523767A5

JP2019523767A5 JP2018563892A JP2018563892A JP2019523767A5 JP 2019523767 A5 JP2019523767 A5 JP 2019523767A5 JP 2018563892 A JP2018563892 A JP 2018563892A JP 2018563892 A JP2018563892 A JP 2018563892A JP 2019523767 A5 JP2019523767 A5 JP 2019523767A5

Authority

JP

Japan

Prior art keywords

delivery system

replication

origin

integrated

episomal dna

Prior art date

2016-12-12

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 108090000623 proteins and genes Proteins 0.000 claims description 84
• 230000003612 virological effect Effects 0.000 claims description 70
• 241000700605 Viruses Species 0.000 claims description 55
• 239000003999 initiator Substances 0.000 claims description 38
• 102000004169 proteins and genes Human genes 0.000 claims description 38
• 230000010076 replication Effects 0.000 claims description 28
• 230000004543 DNA replication Effects 0.000 claims description 27
• 108020004414 DNA Proteins 0.000 claims description 26
• 108091070501 miRNA Proteins 0.000 claims description 26
• 239000002679 microRNA Substances 0.000 claims description 26
• 108020005091 Replication Origin Proteins 0.000 claims description 24
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 22
• 108091027967 Small hairpin RNA Proteins 0.000 claims description 22
• 108020004459 Small interfering RNA Proteins 0.000 claims description 22
• 239000004055 small Interfering RNA Substances 0.000 claims description 22
• 239000002924 silencing RNA Substances 0.000 claims description 19
• 238000000034 method Methods 0.000 claims description 18
• 239000000047 product Substances 0.000 claims description 18
• 241000341655 Human papillomavirus type 16 Species 0.000 claims description 14
• 239000002773 nucleotide Substances 0.000 claims description 12
• 125000003729 nucleotide group Chemical group 0.000 claims description 12
• 239000013612 plasmid Substances 0.000 claims description 12
• 239000012634 fragment Substances 0.000 claims description 9
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 7
• 101150052131 Pgap2 gene Proteins 0.000 claims description 7
• 108010061833 Integrases Proteins 0.000 claims description 6
• 230000002950 deficient Effects 0.000 claims description 6
• 239000013603 viral vector Substances 0.000 claims description 6
• 230000001939 inductive effect Effects 0.000 claims description 5
• 239000003102 growth factor Substances 0.000 claims description 3
• 241000701822 Bovine papillomavirus Species 0.000 claims description 2
• 102100035875 C-C chemokine receptor type 5 Human genes 0.000 claims description 2
• 101710149870 C-C chemokine receptor type 5 Proteins 0.000 claims description 2
• 108010031111 EBV-encoded nuclear antigen 1 Proteins 0.000 claims description 2
• 241000701806 Human papillomavirus Species 0.000 claims description 2
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 2
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 2
• 241000713666 Lentivirus Species 0.000 claims description 2
• 241001631646 Papillomaviridae Species 0.000 claims description 2
• 239000003937 drug carrier Substances 0.000 claims description 2
• 239000008194 pharmaceutical composition Substances 0.000 claims description 2
• 210000004748 cultured cell Anatomy 0.000 claims 2
• 238000002789 length control Methods 0.000 claims 1
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
• 238000012986 modification Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1